Is a complete FRA/HN30 research report available?

No complete published report is available for fra/HN30 (FRA/HN30) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

FRA/HN30 (FRA/HN30)

Frankfurt Stock Exchange: FRA/HN30 · EUR

€0.05

+0.00 (0.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FRA/HN30 analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	3.3M
Revenue (ttm)	83.6K
Net income (ttm)	-557.9K
EPS (ttm)	-€0.02
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 83.6K
Net income (ttm): -557.9K
EPS (ttm): -€0.02
Market cap: 3.3M

All FRA/HN30 indicators

Market & fundamental data

Available fields

144

Groups with data

Currency

CAD

Showing 144 of 144 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	DE
Enterprise value	EUR 2.8M
Exchange	Frankfurt Stock Exchange
Financial currency	CAD
First seen	2026-07-12
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-07-31
Market cap	EUR 3.3M
Price	EUR 0.05
Price currency	EUR
Sic	2836
Symbol	fra/HN30
Website	https://www.restartlife.co

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.93%
EV/Sales	33.19x
FCF yield	-10.45%
P/B ratio	3.44x
P/S ratio	39.42x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	46.03%
Gross Profit	EUR 38,484
Gross Profit Growth5 Y	159.63%
Net Income	EUR -557,916
Pretax Margin	-667.34%
ROA	-43.74
Roa5y	-236.2
ROCE	-60.62
ROE	-99.24
ROIC	-54.55

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-20.01%
Cagr3y	-7.17%
Cagr5y	-42.52%
Revenue Growth5 Y	97.04x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.1
Assets	EUR 1.4M
Cash	EUR 738,900
Current Assets	EUR 902,492
Current Liabilities	EUR 449,855
Debt	EUR 220,012
Debt Equity	EUR 0.23
Debt FCF	EUR -0.64
Equity	EUR 958,956
Interest Coverage	-1,746.1
Liabilities	EUR 460,119
Long Term Assets	EUR 516,583
Long Term Liabilities	EUR 10,264
Net Cash	EUR 518,888
Net Cash By Market Cap	EUR 15.75
Net Cash Growth	115.06%
Net Debt Equity	EUR -0.54
Tangible Book Value	EUR 492,180
Tangible Book Value Per Share	EUR 0.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.01
Net Working Capital	EUR -73,605
Quick ratio	1.75
Working Capital	EUR 454,097
Working Capital Turnover	EUR 0.17

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-126.34%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-20%
200-day SMA	0.06
3Y total return	-20%
50-day SMA	0.05
50-day SMA vs 200-day SMA	50under200
5Y total return	-93.73%
All Time High	26.6
All Time High Change	-99.82%
All Time High Date	2018-01-10
All Time Low	0
All Time Low Change	23,900%
All Time Low Date	2024-11-11
ATR	0
Ch YTD	-38.85
High	0.05
High52	0.08
High52 Date	2026-02-03
High52ch	-38.85%
Low	0.05
Low52	0.03
Low52 Date	2025-09-25
Low52ch	45.46%
Ma50ch	-4.95%
Price vs 200-day SMA	-16.23%
RSI	46.76
RSI Monthly	45.8
RSI Weekly	45.66
Sharpe ratio	0.3x
Sortino ratio	0.5
Total Return	-126.34%
Tr YTD	-38.85
Tr3m	-11.93%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -586,696
Operating margin	-701.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	53,649,186%
Net Borrowing	151,717.3
Shares Insiders	13.96%
Shares Institutions	0.92%
Shares Qo Q	43.85%
Shares Yo Y	126.34%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -660,412
Adjusted OCF	-660,411.6
Average Volume	0x
Bv Per Share	0.02
Ch1y	-20
Ch3m	-11.93
Ch3y	-20
Ch5y	-93.73
Ch6m	-26.72
Change	0%
Change From Open	0
Close	0.05
Days Gap	0
Depreciation Amortization	1,691.4
Earnings Date	2026-08-26
EBIT	EUR -586,696
EBITDA	EUR -584,999
EPS	EUR -0.02
F Score	1
FCF	EUR -344,376
FCF EV Yield	-12.4x
Financing CF	1,429,008
Fiscal Year End	December
Founded	2,004
Goodwill	465,275.5
Investing CF	-524,804
Is Primary Listing	0
Last Report Date	2026-03-31
Last Split Date	2025-01-24
Last Split Type	Reverse
Ma150	0.06
Ma150ch	-16.38%
Ma20	0.05
Ma20ch	0%
Net CF	558,717
Next Earnings Date	2026-08-26
Open	0.05
Ppne	46,745.9
Price Date	2026-07-30
Ptbv Ratio	6.7
Revenue	83,603x
SBC By Revenue	379.24x
Share Based Comp	317,055
Tr6m	-26.72%
Volume	0
Z Score	-34.79

FRA/HN30 (FRA/HN30)

Coverage state: Market snapshot only — no published research

Generate the first FRA/HN30 analysis

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/HN30

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/HN30 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FRA/HN30

Frequently asked questions